Note 4 - Inventories

12 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Inventory Disclosure [Text Block]

Note 4 - Inventories

Inventories consist of the following:

	June 30,
	2024		2023
	(in thousands)
Raw materials	$	266	$	1,301
Work in process		5,725		2,956
Finished goods		6,642		7,738
Inventories	$	12,633	$	11,995

The Company incurred inventory write-downs of $2.3 million for the year ended June 30, 2024, primarily a result of unsalable and slow-moving products and a $0.7 million write-down as part of the wind down of the Consumer Health Segment. The Company incurred inventory write-downs of $2.4 million for the year ended June 30, 2023, primarily as a result of unsalable and slow-moving products.